Shen, Y., Zhang, X., Wei, X., Liang, J., Sun, G., Zhao, J., Liu, H., Chen, J., Hu, X., Chen, Y., Yao, J., Chen, N., Nie, L., Zhang, P., Li, X., Wei, Q., Shen, P., Liu, J., Liu, Z., Zeng, H. (2025). VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps616